Taro Pharmaceutical
TARO
#4588
Rank
HK$12.53 B
Marketcap
HK$333.40
Share price
0.00%
Change (1 day)
7.14%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): HK$4.78

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$4.73. In 2021 the company made an earnings per share (EPS) of HK$0.31 an increase over its 2020 EPS that were of -HK$61.37.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$4.78
2021HK$0.31-100.51%
2020-HK$61.37-222.45%
2019HK$50.12-18.02%
2018HK$61.1453.01%
2017HK$39.96-55.95%
2016HK$90.70-13.41%
2015HK$104.7436.92%
2014HK$76.5037.71%
2013HK$55.5521.15%
2012HK$45.8544.15%
2011HK$31.81175.17%
2010HK$11.56-48.8%
2009HK$22.58
2005HK$0.23-91.89%
2004HK$2.87-82.55%
2003HK$16.4535.9%
2002HK$12.1039.29%
2001HK$8.69140.86%
2000HK$3.6169.09%
1999HK$2.13139.13%
1998HK$0.8964.29%
1997HK$0.54-36.36%
1996HK$0.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.43 204.92%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.13 198.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.29 2,209.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$15.52-427.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$27.16 473.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$29.02 513.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland